• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
SONN

SONN

Sonnet BioTherapeutics Holdings, Inc.

NASDAQHealthcareBiotechnologyUS

USD1.26

-1.84 (-59.35%)

Company Profile

CEO

Raghu Rao

IPO Date

2006-10-31

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$3.16

Prev. Close

$3.10

Day Low

$1.26

Day High

$3.23

52W Low

$1.08

52W High

$19.30

Market Cap

$0.01B

Volume

10.43M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

45.2%

Avg Negative

2.8%

Avg Neutral

52.0%

News Feed

Sonnet BioTherapeutics Announces Change in Date of Annual Meeting

Accesswire·6/14/2021·↓ negative

Sonnet BioTherapeutics Announces Issuance of U.S. Patent for Platform Technology

Accesswire·6/8/2021·↑ positive

SONN Stock: Over 6% Increase Pre-Market Explanation

Pulse2·5/10/2021·↑ positive

Sonnet BioTherapeutics Completes Successful GLP Repeat Dose Toxicology Study of IL12-FHAB (SON-1010) in Non-Human Primates (NHP)

Accesswire
·5/10/2021
·↑ positive

SONN Stock: From $2.37 To $2.57 (8.44% Increase) Pre-Market Explanation

Pulse2·5/3/2021·↑ positive

3 Penny Stocks With Huge Potential in May 2021

PennyStocks·5/3/2021·↑ positive

Sonnet BioTherapeutics Completes Licensing Agreement with New Life Therapeutics

Accesswire·5/3/2021·↑ positive

Hot Penny Stocks To Buy on Robinhood? Here's 4 To Watch

PennyStocks·4/30/2021·↓ negative

Sonnet BioTherapeutics Provides 2021 Business Update

Accesswire·3/29/2021·↑ positive

Sonnet BioTherapeutics Appoints Richard Kenney as Chief Medical Officer and Manuel Dafonseca as Head of Clinical Operations

Accesswire·3/22/2021·↓ negative